Capcium is committed to producing high-quality products that meet FDA, Health Canada, and EMEA standards. We possess a Site License from Health Canada’s Natural Health Products Directorate (NHPD) and our strict and highly monitored processes ensure that we are fully compliant with all Canadian and U.S. cGMP regulatory requirements.
Safe, High-Quality Products Every Time
In November 2015 Capcium received its Health Canada site license to become a North American manufacturer of softgel products for the nutraceutical industry and began producing softgel capsules for nutraceutical customers in a designated GMP location.
Currently, Capcium is producing high-quality, value-added CBD softgel capsules for the medicinal market in Canada at our Licensed Producer partners’ facilities.
Capcium is presently filing its application for a processing license under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and anticipates receiving it for the opening of our new facility.